Barbara Kollerits

Innsbruck, 6020, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Genetic architecture and cross-platform validation of apolipoprotein A-IV concentrations.

Genetic architecture and cross-platform validation of apolipoprotein A-IV concentrations.

Journal: Genome biology

Published: December 02, 2025

Higher afamin concentrations are associated with higher fatty liver indices: Population-based KORA F4/FF4 study.

Higher afamin concentrations are associated with higher fatty liver indices: Population-based KORA F4/FF4 study.

Journal: European journal of clinical investigation

Published: January 12, 2025

Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study.

Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study.

Journal: Journal of internal medicine

Published: November 08, 2024

Association of Serum Afamin Concentrations With Kidney Failure in Patients With CKD: Findings From the German CKD Cohort Study.

Association of Serum Afamin Concentrations With Kidney Failure in Patients With CKD: Findings From the German CKD Cohort Study.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: June 07, 2024

Correction: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.

Correction: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.

Journal: BMC cancer

Published: March 20, 2024

Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.

Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.

Journal: BMC cancer

Published: March 24, 2023

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function.

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: January 28, 2022

Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study.

Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study.

Journal: Journal of internal medicine

Published: December 16, 2021

Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.

Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.

Journal: Journal of internal medicine

Published: August 03, 2021

Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study.

Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study.

Journal: Atherosclerosis

Published: October 01, 2020

A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests.

A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: August 27, 2020

Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease.

Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease.

Journal: Journal of internal medicine

Published: September 18, 2019

Showing 1-12 of 52

Last Updated: 09/26/2026